Literature DB >> 1382831

An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types.

Y Yamamoto1, K Izumi, H Otsuka.   

Abstract

METHODS: Immunoreactivity for epithelial membrane antigen (EMA), cytokeratin, and vimentin was investigated in 15 papillary thyroid carcinomas (PTC) with distant metastases, 25 PTC without distant metastases, and 34 occult PTC without distant metastases that were found incidentally at autopsy.
RESULTS: More than 50% of the tumor cells were positive for EMA in 7 (47%) of 15 PTC with distant metastases, 0 (0%) of 25 PTC without distant metastases, and 1 (3%) of 34 occult PTC. The incidence of EMA positivity in PTC with distant metastases was significantly different from that of both PTC without distant metastases and occult PTC (P < 0.001). Cytokeratin reactivity was similar in the three groups, and almost all PTC stained strongly for cytokeratin. Concerning vimentin positivity, there were no significant differences in three groups; however, PTC with distant metastases tended to stain more weakly or focally than PTC without distant metastases or occult PTC.
CONCLUSIONS: These results suggest that EMA reactivity may be a useful factor for anticipating the individual risk of distant metastasis or death from PTC at the time of initial surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382831     DOI: 10.1002/1097-0142(19921101)70:9<2326::aid-cncr2820700919>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience.

Authors:  Atsuhiko Sakamoto
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

3.  Diagnostic and prognostic value of Stanniocalcin 1 expression in papillary thyroid cancer.

Authors:  Sevinç Sengun; Hakan Korkmaz; Metin Ciris; Ramazan Oguz Yüceer; Serife Mehtap Boyluboy; Mehmet Kiran
Journal:  Endocrine       Date:  2022-07-04       Impact factor: 3.925

4.  Papillary Thyroid Carcinoma Overexpresses Fully and Underglycosylated Mucins Together with Native and Sialylated Simple Mucin Antigens and Histo-Blood Group Antigens.

Authors:  Pedro Alves; Paula Soares; Elsa Fonseca; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

5.  Clinicopathologic and Prognostic Significance of the Expression of Mucins, Simple Mucin Antigens and Histo-Blood Group Antigens in Papillary Thyroid Carcinoma.

Authors:  Pedro Alves; Paula Soares; Simone Rossi; Elsa Fonseca; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

6.  Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.

Authors:  Dong Wook Kim; Robert L Walker; Paul S Meltzer; Sheue-yann Cheng
Journal:  Carcinogenesis       Date:  2013-05-22       Impact factor: 4.944

Review 7.  Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.

Authors:  Rita Niciporuka; Jurijs Nazarovs; Arturs Ozolins; Zenons Narbuts; Edvins Miklasevics; Janis Gardovskis
Journal:  Medicina (Kaunas)       Date:  2021-10-19       Impact factor: 2.948

Review 8.  Vimentin Diversity in Health and Disease.

Authors:  Frida Danielsson; McKenzie Kirsten Peterson; Helena Caldeira Araújo; Franziska Lautenschläger; Annica Karin Britt Gad
Journal:  Cells       Date:  2018-09-21       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.